Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Archives of Virology|January 1, 1995
HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretorsM Margalith, R T D'Aquila, D J Manion, et al.
Scientific Reports|June 3, 2025
Use of deep learning-based NLP models for full-text data elements extraction for systematic literature review tasksJingcheng Du, Dong Wang, Bin Lin, et al.
JMIR Medical Informatics|June 21, 2024
Natural Language Processing-Powered Real-Time Monitoring Solution for Vaccine Sentiments and Hesitancy on Social Media: System Development and ValidationLiang-Chin Huang, Amanda L Eiden, Long He, et al.
Journal of Telemedicine and Telecare|November 25, 2010
Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility studyNeal J Meropol, Mary B Daly, Hetal S Vig, et al.
BMC Bioinformatics|June 18, 2009
FuGEFlow: data model and markup language for flow cytometryYu Qian, Olga Tchuvatkina, Josef Spidlen, et al.
Journal of the American Medical Informatics Association : JAMIA|November 12, 2023
AutoCriteria: a generalizable clinical trial eligibility criteria extraction system powered by large language modelsSurabhi Datta, Kyeryoung Lee, Hunki Paek, et al.
Journal of the American Medical Informatics Association : JAMIA|March 6, 2021
COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data modelJingqi Wang, Noor Abu-El-Rub, Josh Gray, et al.
Arxiv|September 10, 2020
COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data modelJingqi Wang, Noor Abu-El-Rub, Josh Gray, et al.
JMIR Medical Informatics|October 23, 2024
Accelerating Evidence Synthesis in Observational Studies: Development of a Living Natural Language Processing-Assisted Intelligent Systematic Literature Review SystemFrank J Manion, Jingcheng Du, Dong Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
Pageof 5